Javascript must be enabled to continue!
Amyotrophic Lateral Sclerosis
View through CrossRef
Abstract
Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons. Cognitive impairment occurs in a significant proportion of those affected. Numerous theories of pathogenesis have been advanced. The most cogent hypothesis is that genetic susceptibilities to neurodegeneration interact with environmental exposures, leading to neuronal injury, glial activation and neuronal death. Modern tools of molecular and cell biology and constructive international collaborations have provided insights into the factors that increase disease susceptibility. The important observation that genes associated with
ribonucleic acid
(RNA) processing are implicated in disease pathogenesis will undoubtedly influence the direction of research in the coming years. These factors, combined with improvements in clinical trial design, and an improved understanding of the limitations of translating positive findings from animal models to human subjects, are likely to lead to new and successful therapeutic options for patients in the near future.
Key concepts:
Amyotrophic lateral sclerosis is a motor system degeneration.
The incidence of amyotrophic lateral sclerosis is relatively uniform in populations of European ancestry. Disease frequency is lower in populations of mixed ancestry.
Amyotrophic lateral sclerosis (ALS) is associated with cognitive decline in up to 50% of cases, and with dementia in up to 20%. There is an acknowledged clinical, imaging, neuropathologic and neurogenetic overlap between ALS and frontotemporal dementia.
Amyotrophic lateral sclerosis is a complex genetic condition, in which genetic susceptibility interacts with environmental exposures to produce a neurodegenerative cascade.
The progression of amyotrophic lateral sclerosis is due in part to the activation of glia, which contributes to the process of neurodegeneration.
Recent genetic studies of amyotrophic lateral sclerosis have implicated genes involving RNA regulation, including transcription, RNA splicing, RNA transport and translation.
Title: Amyotrophic Lateral Sclerosis
Description:
Abstract
Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons.
Cognitive impairment occurs in a significant proportion of those affected.
Numerous theories of pathogenesis have been advanced.
The most cogent hypothesis is that genetic susceptibilities to neurodegeneration interact with environmental exposures, leading to neuronal injury, glial activation and neuronal death.
Modern tools of molecular and cell biology and constructive international collaborations have provided insights into the factors that increase disease susceptibility.
The important observation that genes associated with
ribonucleic acid
(RNA) processing are implicated in disease pathogenesis will undoubtedly influence the direction of research in the coming years.
These factors, combined with improvements in clinical trial design, and an improved understanding of the limitations of translating positive findings from animal models to human subjects, are likely to lead to new and successful therapeutic options for patients in the near future.
Key concepts:
Amyotrophic lateral sclerosis is a motor system degeneration.
The incidence of amyotrophic lateral sclerosis is relatively uniform in populations of European ancestry.
Disease frequency is lower in populations of mixed ancestry.
Amyotrophic lateral sclerosis (ALS) is associated with cognitive decline in up to 50% of cases, and with dementia in up to 20%.
There is an acknowledged clinical, imaging, neuropathologic and neurogenetic overlap between ALS and frontotemporal dementia.
Amyotrophic lateral sclerosis is a complex genetic condition, in which genetic susceptibility interacts with environmental exposures to produce a neurodegenerative cascade.
The progression of amyotrophic lateral sclerosis is due in part to the activation of glia, which contributes to the process of neurodegeneration.
Recent genetic studies of amyotrophic lateral sclerosis have implicated genes involving RNA regulation, including transcription, RNA splicing, RNA transport and translation.
Related Results
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Abstract
TDP-43 is mislocalized from the nucleus and aggregates within the cytoplasm of affected neurons in cases of amyotrophic lateral sclerosis. TDP-43 pathology ...
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Abstract
Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease that targets motor neurons in the cerebral cortex, medulla oblongata, ...
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis
Abstract
Metabolic imbalance is associated with amyotrophic lateral sclerosis progression. Impaired glucose oxidation and increased reliance on fatty acid oxidation ...
Genetic aspects of amyotrophic lateral sclerosis
Genetic aspects of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a progressive, incurable neurodegenerative disease characterized by motor neuron loss and the development of paralysis and skeletal muscle atrophy....
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Abstract
Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive up...
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
INTRODUCTION. Despite the fact that more than 150 years have passed since the first mention of amyotrophic lateral sclerosis (ALS), the issues of etiology, pathogenesis, diagnosis ...
Serum Neurofilament Light Chain as a Discriminatory Biomarker and Predictor of Disease Trajectory in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
Serum Neurofilament Light Chain as a Discriminatory Biomarker and Predictor of Disease Trajectory in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
Background: Amyotrophic lateral sclerosis is a rapidly progressive, fatal neurodegenerative disorder characterized by the deterioration of upper and lower motor neurons. Diagnostic...
Safety and efficacy of edaravone in well-defined Iranian patients with amyotrophic lateral sclerosis: A parallel-group single-blind trial
Safety and efficacy of edaravone in well-defined Iranian patients with amyotrophic lateral sclerosis: A parallel-group single-blind trial
Background: This parallel-group single-blind trial evaluates the safety and efficacy of Edaravone, as a free radical scavenger, in a highly selective subgroup of Iranian patients w...

